| Year |
Citation |
Score |
| 2018 |
Liu BW, Wang TJ, Li LL, Zhang L, Liu YX, Feng JY, Wu Y, Xu FF, Zhang QS, Bao MZ, Zhang WY, Ye LH. Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer. Acta Pharmacologica Sinica. PMID 29925919 DOI: 10.1038/S41401-018-0015-9 |
0.309 |
|
| 2016 |
Wang Y, Fang R, Cui M, Zhang W, Bai X, Wang H, Liu B, Zhang X, Ye L. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer. Cancer Letters. PMID 27765671 DOI: 10.1016/J.Canlet.2016.10.018 |
0.351 |
|
| 2015 |
Li L, Fang R, Liu B, Shi H, Wang Y, Zhang W, Zhang X, Ye L. Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth. Oncogene. PMID 26657153 DOI: 10.1038/Onc.2015.476 |
0.316 |
|
| 2010 |
Liu B, Bell AW, Paranjpe S, Bowen WC, Khillan JS, Luo JH, Mars WM, Michalopoulos GK. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice. Hepatology (Baltimore, Md.). 52: 1060-7. PMID 20812357 DOI: 10.1002/Hep.23794 |
0.493 |
|
| 2010 |
Dawes J, Liu B, Mars W, Michalopoulos G, Khillan JS. Multiple ovarian transplants to rescue a transgenic line of mice. Lab Animal. 39: 191-3. PMID 20485359 DOI: 10.1038/Laban0610-191 |
0.431 |
|
| 2009 |
Liu B, Paranjpe S, Bowen WC, Bell AW, Luo JH, Yu YP, Mars WM, Michalopoulos GK. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. The American Journal of Pathology. 175: 717-24. PMID 19574424 DOI: 10.2353/Ajpath.2009.081129 |
0.468 |
|
| Show low-probability matches. |